PMV Pharmaceuticals Inc. (NASDAQ: PMVP) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT PMV PHARMACEUTICALS INC.

PMV Pharmaceuticals Inc. (NASDAQ: PMVP)
Listen to this Section


$1.18
+0.0150 ( +1.29% ) 97.8K

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Clinical Trial Pipeline Stages


Drug Name Stage
Rezatapopt/ PC14586 (p53 reactivator)DetailsSolid tumor/s, Cancer Phase 2
Rezatapopt/ PC14586 (p53 reactivator) + KEYTRUDADetailsSolid tumor/s, Cancer Failed
Rezatapopt/ PC14586 (p53 reactivator) +/- azacitidineDetailsCancer, Blood cancer, Acute myeloid leukemia Phase 1b

Market Data


Open $1.18
Previous Close $1.16
Volume 97.8K
Market Cap $61.86M
Day Range $1.16 - $1.20
52 Week Range $0.91 - $1.88
Shares Outstanding 53.33M
Change % +1.29%
Net Change ▲ 0.0150
Insider Ownership -0.02%
Exchange NASDAQ
SectorHealthcare
IndustryMedicinal Chemicals and Botanical Products
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,128,753.00

Date Type Amount Purchased Purchaser
2024-06-10 Sale -67500.00 Gallagher Carol Giltner
2024-06-10 Sale -67500.00 Heyman Richard A.
2024-06-10 Sale -67500.00 Stelzer Laurie
2024-06-10 Sale -67500.00 LEVINE ARNOLD J
2024-06-10 Sale -67500.00 FLOWERS KIRSTEN
2024-06-10 Sale -67500.00 BAUM CHARLES M
2024-01-22 Sale -95555.00 Jalota Deepika
2024-01-22 Sale -82220.00 Carulli Michael
2024-01-22 Sale -163890.00 Mack David Henry
2023-11-24 Sale -87786.00 ORBIMED ADVISORS LLC

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 69 Nov 12, 2025
8-k 8K-related 11 Nov 12, 2025
4 Insider transactions 1 Oct 29, 2025
4 Insider transactions 1 Oct 27, 2025
4 Insider transactions 1 Sep 12, 2025
8-k 8K-related 57 Sep 10, 2025
10-q Quarterly Reports 69 Aug 07, 2025
8-k 8K-related 11 Aug 07, 2025
4 Insider transactions 1 Jul 03, 2025
4 Insider transactions 1 Jul 03, 2025

Latest News


× Before browsing our site, please accept our cookies policy